Wegovy Pill Crosses Two Million Scripts in Sixteen Weeks as Foundayo Holds at 7,335
Novo's oral GLP-1 is now a population-health event at $149 a month, while Lilly's launch trails the same week's revenue model by twenty-fourfold.
Life
Cherie DeVaux's Mother Once Asked If Winning The Derby Was A Little Lofty
On the Mother's Day after her daughter became the first woman to train a Kentucky Derby winner, Janet DeVaux's old worry — that the goal was a little lofty — reads as honest.
Twenty-Three Right Whale Calves And Twenty Mothers Close The Best Season Since Two Thousand Nine
Twenty-three calves and twenty returning mothers closed the right whale season — and the calving interval compressed back toward the historic norm for the first time in years.
Utah Measles Cases Reach 638 With FLDS Communities Below Eighty Percent MMR Coverage as PAHO November Review Approaches
Utah's outbreak hits 638 cases — 441 this year — and the chain runs from RFK Jr.'s 2025 CDC autism-page change through confidence damage to FLDS-community uptake below 80 percent.
Two Big GLP-1 Studies Reach Opposite Conclusions on Mental Health
A 95,490-adult Swedish cohort shows semaglutide cuts new psychiatric illness odds by roughly 40 percent — and a same-month comparator-class study found the opposite against other diabetes drugs.
Wastewater Surveillance Watches a Third U.S. Metro for Measles as PAHO's Deadline Closes
Newark and Atlanta wastewater have flagged measles RNA for two consecutive weeks; a third metro is now on the watch list as PAHO's November elimination review approaches.
Foundayo Week Four Hits 7,335 Prescriptions, Twenty-Four Times Below the Bar Analysts Set
Lilly's oral GLP-1 wrote 7,335 scripts in its fourth week — 31 percent growth on the week, but still 24 times short of the 90,000 weekly bar RBC set for week 12.
Idaho Holds Its Bird-Flu Vector Watch as USDA's Loosened Dairy Testing Enters Its Sixth Week
Idaho's H5N1 dairy vector watch holds inside the 18-state cumulative count and 70 confirmed human cases since 2024 — and the system is one host shift from a new genotype clock.
Braunwald Memorial Fund Crosses Its First Million as the Mentorship Arc Holds
The AHA-NHLBI fund named for Eugene Braunwald has raised more than a million dollars in its first three weeks, funding the named-mentorship infrastructure his textbook helped invent.
ER Visits for Tick Bites Hit a Nine-Year April High as CDC Projects 500,000 Lyme Cases
April emergency-room tick-bite visits ran at 96 per 100,000 — the highest April rate since 2017 — and CDC now projects more than half a million Lyme diagnoses for 2026.
Americans Will Spend A Record Thirty-Eight Billion Dollars On Mother's Day As The Fertility Rate Falls To One Point Five Nine Four
NRF forecasts a record $38 billion in Mother's Day spending and $284.25 per person — even as the Q3 2025 fertility rate prints at 1.594, the lowest on record.
Tequila Distributors Print Flat Margarita Volume as the Cinco de Mayo Cycle Ends
Day five out from the holiday: distributor sell-through ran flat to slightly down against 2025, and the durable artifact is the Jose Cuervo cultural-cycle print, not the bar tab.
NICE Sets June 10 Reconsultation as the Cochrane Versus Kisunla Evidence Arc Reaches Day Twenty-Five
NICE's June 10 reconsultation is the operative artifact in the Cochrane-versus-Kisunla fight; the carer-economics dispute, not the trial-design one, is now the regulator's center of gravity.
Monocyte Aging Biomarker for Late-Life Depression Enters Its Validation Cohort
The Penn-NYU monocyte epigenetic-age assay for late-life cognitive depression is moving from a 440-person observation cohort into prospective validation — inflammation-aging gets a measurable proxy.